_____________________________________________________________________________________________________________
201 KAR 2:010 Schools Approved by Board. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. The amendment is just to update the referenced standards for pharmacy programs to the most currently available versions from the Accreditation Council on Pharmaceutical Education.
201 KAR 2:090 Reference material and prescription equipment. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. The amendment removes the section (1)(b)(1-9), (2) which concerning the pharmacist in charge determining what references and equipment are appropriate. In a “companion” amendment proposal, the Board is proposing to add that information to the pharmacist in charge regulation- 201 KAR 2:205.
201 KAR 2:116 Substitution of Drugs, Biologics and Biosimilar Products. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. The amendment is an update to the materials incorporated by reference, specifically the Approved Drug Products and Therapeutic Equivalence Evaluations (orange book); “List of Licensed Biological Products with Reference Product Exclusivity and Biosimiarlity or Interchangeability Evaluations (purple book). Additionally, “Approved Animal Drug Products” (green book) was added to include references for drugs for animals.
201 KAR 2:160 Licensees; Inactive Status. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment clarifies language for understanding and consistency.
201 KAR 2:180 Pharmacy Sanitation. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment adds provisions related maintenance of proper temperature and moisture levels within a facility to ensure integrity of drug products.
201 KAR 2:185 Noncontrolled Substance Prescription Drug Refills. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment adds clarifying language pertaining to prescription drug refills during a period of declared emergency pursuant to KRS 315.500.
201 KAR 2:190 Return of Prescription Drugs. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment adds language from KRS 217 that clarifies what drugs can and cannot be accepted as a return to a pharmacy.
201 KAR 2:050 Licenses and permits; Fees. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. This amendment increases license and renewal fees for pharmacies, manufacturers and wholesalers.
201 KAR 2:205 Pharmacist In Charge. Amendment, filed 12/12/2025. Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment includes the requirement to maintain proper reference and equipment to the regulation (previously included in 201 KAR 2:090).
201 KAR 2:215 Nuclear Pharmacy Services. Certification. No change to regulation. Certified 12/5/2025.
201 KAR 2:250 Pharmacist Recovery Network Committee. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. The amendment adds confidentiality protections of KRS 315.126 and KRS 61.810(k) to the governing regulation for clarity and consistency.
201 KAR 2:260 Automated Pharmacy Systems in Residential Hospice Facilities. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment adds reference to 201 KAR 2:045 for consistency related to the supervision required for pharmacy technicians that work in residential hospice facilities.
201 KAR 2:280 Prescription Dispensing for Formulary Compliance. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment provides mechanism for electronic prescription systems to be used to clearly for “formulary compliance approval” including use of notes section, check box or other similar designation.
201 KAR 2:300 Common Database. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment clarifies non resident pharmacy requirements for compliance with administrative guidance on the issue.
201 KAR 2:330 Emergency Pharmacy Powers. Amendment, filed 12/12/2025. Public Comments received through February 28, 2026. Public hearing scheduled for February 27, 2026, at 9:00 EST held via Zoom. Amendment adds clarification concerning the refill authority of pharmacists during a declared emergency pursuant to KRS 217.215.